ApicHope(SZ:300723) Xin Lang Cai Jing·2025-10-31 02:58Core Insights - Yipinhong Pharmaceutical Group Co., Ltd. experienced a stock price increase of 5.72%, reaching 53.79 CNY per share, with a trading volume of 290 million CNY and a turnover rate of 1.32%, resulting in a total market capitalization of 24.297 billion CNY [1] Company Overview - Yipinhong Pharmaceutical was established on February 4, 2002, and went public on November 16, 2017. The company is located in Guangzhou International Biological Island, Huangpu District, Guangzhou, Guangdong Province [1] - The company's main business includes the research, production, and sales of its own pharmaceuticals, as well as the sales of agent pharmaceuticals. The revenue composition is as follows: children's medicine 61.12%, chronic disease medicine 22.71%, and others 16.17% [1] Fund Holdings - According to data from the top ten holdings of funds, one fund under Huaxia Fund has a significant position in Yipinhong. Huaxia New Jinhui Mixed A (004048) held 23,000 shares in the third quarter, accounting for 2.58% of the fund's net value, ranking as the sixth-largest holding [2] - The fund was established on March 8, 2017, with a latest scale of 14.8028 million CNY. Year-to-date returns are 16.22%, ranking 5037 out of 8154 in its category; one-year returns are 17%, ranking 4763 out of 8046; and since inception, returns are 21.01% [2] - The fund manager, Hu Jie, has been in position for 2 years and 210 days, with a total asset scale of 52.9889 million CNY. The best fund return during his tenure is 11.97%, while the worst is 11.68% [2]